FDA Advisory Panel Approves Novel Cholesterol-Lowering Drug

An advisory committee for the Food and Drug Administration has recommended the approval of a novel, injectable cholesterol-lowering drug called alirocumab, though many committee members have noted certain restrictions for its use and have requested further data on the drug’s ability to reduce the risk of heart problems. According to the Centers for Disease Control […]

Asco 2015 Round-Up: Immunotherapy Continues to Come of Age

As you’ll have probably spotted by the array of cancer stories in the media over the last week, the world’s biggest annual cancer conference has just taken place. The annual American Society of Clinical Oncology (ASCO) meeting brings together over 30,000 oncology professionals from around the world to discuss research into new treatments, practices and […]